Company research / INBP
Integrated Biopharma Inc (INBP)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Jun 30
For the year ended 2026-06-30, Integrated Biopharma Inc reported revenue of $43.87M. Revenue fell 19.3% from the prior annual period.
Key ratios (year ended 2026-06-30)
1.8%
Gross margin
-6.2%
Operating margin
-6.5%
Net margin
-16.1%
Return on year-end equity
-19.3%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.